APS

Aptose Bio

• Dow Jones·04/01 21:08

  *News On Aptose Biosciences Inc. (APTO) Now Under APS.T

• Dow Jones·04/01 19:15

  Aptose Biosciences' Shares Tumble Ahead of Nasdaq Delisting

• Dow Jones·03/28 17:57

  Aptose Biosciences Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·03/28 17:57

  Aptose Biosciences Price Target Raised to $6.00/Share From $2.00 by HC Wainwright & Co.

• Dow Jones·03/28 12:03

  *Aptose Biosciences FY24 Loss $25.4M >APTO

• Dow Jones·03/28 12:01

  Press Release: Aptose Reports Year End 2024 Results and Corporate Highlights

• Dow Jones·03/28 12:01

  Press Release: Aptose Reports Year End 2024 -2-

• Dow Jones·02/18 21:33

  *Aptose Announces 1-for-30 Reverse Shr Split

• Dow Jones·02/12 17:05

  Aptose Biosciences Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

• Dow Jones·12/10/2024 12:01

  Aptose Biosciences Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

• Dow Jones·12/03/2024 17:31

  Aptose Biosciences Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

• Dow Jones·11/20/2024 18:11

  Aptose Biosciences Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·11/20/2024 18:11

  Aptose Biosciences Price Target Cut to $2.00/Share From $7.00 by HC Wainwright & Co.

• Dow Jones·11/08/2024 21:01

  *Aptose Biosciences 3Q Loss/Shr 37c >APTO

• Dow Jones·08/30/2024 20:30

  Press Release: Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib